All posts by Amber Khan

TRACT Therapeutics, Inc. Completes Phase I Safety Trial

TRACT Therapeutics, Inc. Completes Phase I Safety Trial Using a Patient’s Immune Cells to Prevent Organ Rejection Safety Data Presented at the American Transplant Congress Meeting Demonstrated Excellent Patient Tolerability and Supports the Start of a Phase II Trial Additional Data Analysis Showed Positive Signals Toward Efficacy CHICAGO–(BUSINESS WIRE)– TRACT Continue reading